Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.765 | -2.38416858031 | 74.03 | 75.32 | 69.13 | 586038 | 72.48879519 | CS |
| 4 | -14.025 | -16.2533317882 | 86.29 | 87.66 | 69.13 | 431002 | 77.03036931 | CS |
| 12 | -13.675 | -15.9122643705 | 85.94 | 91.5 | 69.13 | 498333 | 80.0349442 | CS |
| 26 | -12.995 | -15.2416138869 | 85.26 | 113.51 | 69.13 | 508563 | 90.23599106 | CS |
| 52 | -12.845 | -15.0922335801 | 85.11 | 113.51 | 61.795 | 458908 | 83.09380635 | CS |
| 156 | 57.245 | 381.125166445 | 15.02 | 113.51 | 7.09 | 373732 | 59.91157396 | CS |
| 260 | 54.165 | 299.254143646 | 18.1 | 113.51 | 7.09 | 337810 | 57.05991778 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
